At a glance
ClinicalIndex Comparison RecordN/ACompleted· 29 enrolled
Drug / intervention
Vest Treatment (high frequency chest wall oscillation)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Assess the Efficacy and Effectiveness of High-Frequency Chest Wall Oscillation (HFCWO) in Preventing Pulmonary Exacerbations in Children With Muscle Weakness and Restrictive Lung Disease CR-0088
In Brief
A clinical study evaluating Vest Treatment (high frequency chest wall oscillation) for Cerebral Palsy. Completed, enrolled 29 participants across 1 site.
Detailed Summary
To asssess efficacy of airway clearance provided by Vest therapy (HFCWO) in the reduction of respiratory exacerbations requiring hospitalization or antibiotic utilization in patients with muscle weakness and restrictive lung disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Palsy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
First PostedAug 2008
Primary CompletionOct 2010
Study CompletionJul 2011
TodayJul 2026
First PostedAug 21, 2008
Enrollment StartAug 1, 2008
Primary CompletionOct 1, 2010
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 17.9 years ago
Interventions
Vest Treatment (high frequency chest wall oscillation)device
twice daily for 15-20 minutes